By Reuters
Johnson & Johnson said on Friday it has recalled 16,000 bottles of its Risperdal schizophrenia treatment and another 24,000 bottles of a generic formulation of the medicine due to consumer reports of odors in the products.
The company -- which has been beset over the past two years with recalls of consumer medicines, prescription drugs and medical devices -- said the latest two
No comments:
Post a Comment